hyaluronoglucosaminidase has been researched along with tyrosine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Konikova, AS; Korotkina, RN; Kritzman, MG | 1 |
| Denney, JW; Funderburk, SS; Lively, DH; Solenberg, JM; Westhead, JE; Whitney, JG | 1 |
| Korotkina, RN; Perova, NV; Zhadanov, VS | 1 |
| Bertelsen, TI; Ehlers, N | 1 |
| Korotkina, RN; Mitlina, IM | 1 |
| Brada, Z; Kolárová, M; Tobiska, J | 1 |
| Soru, E; Zaharia, O | 1 |
| Chang, NS; Doherty, J; Ensign, A | 1 |
| Barkley, J; Barycki, JJ; Bharadwaj, AG; Casper, A; Simpson, MA; Zhang, L | 1 |
9 other study(ies) available for hyaluronoglucosaminidase and tyrosine
| Article | Year |
|---|---|
The fate of parenterally injected 14C-hyaluronidase.
Topics: Adrenal Glands; Animals; Brain; Carbon Isotopes; Carcinoma, Hepatocellular; Hyaluronoglucosaminidase; Injections; Kidney; Liver; Liver Neoplasms; Lymph Nodes; Male; Neoplasms, Experimental; Pancreas; Rats; Testis; Thymus Gland; Tyrosine | 1968 |
Anticapsin, a new biologically active metabolite: screening and assay procedures.
Topics: Agar; Amino Acids; Antimetabolites; Bacteriophages; Cell Wall; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Ethers, Cyclic; Hyaluronic Acid; Hyaluronoglucosaminidase; Ketones; Lysogeny; Methods; Streptococcus pyogenes; Temperature; Tyrosine | 1972 |
[Distribution of parenterally administered C 14 -hyaluronidase in the organs and tissues in experimental arteriosclerosis].
Topics: Animals; Aorta; Arteriosclerosis; Blood Proteins; Brain; Carbon Isotopes; Diet, Atherogenic; Disease Models, Animal; Fibrin; Hyaluronoglucosaminidase; Kidney; Liver; Male; Methods; Muscles; Myocardium; Pancreas; Rats; Tendons; Time Factors; Tyrosine | 1971 |
Morphological and histochemical studies on fibrillopathia epitheliocapsularis.
Topics: Aged; Amylases; Arginine; Cataract; Cysteine; Cystine; Endopeptidases; Epithelium; Eye Diseases; Histocytochemistry; Humans; Hyaluronoglucosaminidase; In Vitro Techniques; Lens, Crystalline; Microscopy, Electron; Middle Aged; Ribonucleases; Time Factors; Tryptophan; Tyrosine | 1969 |
[Utilization by organs and tissues of parenterally administered C14-hyaluronidase].
Topics: Adrenal Glands; Animals; Aorta; Brain; Carbon Isotopes; Cell Nucleus; Cytoplasm; Female; Hyaluronoglucosaminidase; Injections; Intestine, Small; Kidney; Liver; Liver Regeneration; Lung; Male; Muscles; Myocardium; Ovary; Pancreas; Rats; Spleen; Testis; Thymus Gland; Thyroid Gland; Tyrosine; Uterus | 1970 |
Host-tumour relationship. XXIX. Hyaluronidase activity and seromucoid concentration in blood serum of patients with cancer.
Topics: Animals; Blood; Female; Glucosamine; Humans; Hyaluronoglucosaminidase; Mucus; Neoplasms; Rats; Sarcoma, Experimental; Sarcoma, Yoshida; Tyrosine; Uterine Cervical Neoplasms; Uterine Neoplasms | 1970 |
Presence of N-acetyl group in hyaluronidase.
Topics: Alanine; Amino Acids; Animals; Cattle; Chromatography, Ion Exchange; Chromatography, Thin Layer; Glutamates; Hyaluronoglucosaminidase; Hydrazines; Leucine; Male; Peptides; Phenylalanine; Testis; Tyrosine | 1967 |
JNK1 physically interacts with WW domain-containing oxidoreductase (WOX1) and inhibits WOX1-mediated apoptosis.
Topics: Animals; Anisomycin; Apoptosis; Arginine; Cell Cycle; Cell Survival; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Activation; Fibroblasts; Genes, Dominant; Humans; Hyaluronoglucosaminidase; Mice; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Monocytes; Oxidoreductases; Phosphorylation; Precipitin Tests; Protein Binding; Protein Structure, Tertiary; Signal Transduction; Time Factors; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Two-Hybrid System Techniques; Tyrosine; U937 Cells; Ultraviolet Rays; WW Domain-Containing Oxidoreductase | 2003 |
Hyaluronidase activity of human Hyal1 requires active site acidic and tyrosine residues.
Topics: Acids; Biocatalysis; Catalytic Domain; Cell Line; Crystallography, X-Ray; Disulfides; Glycosylation; Humans; Hyaluronoglucosaminidase; Hydrogen-Ion Concentration; Kinetics; Models, Molecular; Mutation; Oligosaccharides; Protein Structure, Tertiary; Tyrosine | 2009 |